ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (136)    NLM QUALITY MEASURE GROUPS (802.3)

Name Value
MEASURE TITLE ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication
CMS ID CMS136v3
VERSION NUMBER 3
SHEETNAME ADHD_Follow-Up
DEVELOPER National Committee for Quality Assurance
STEWARD National Committee for Quality Assurance
COPYRIGHT
Physician Performance Measure (Measures) and related data specifications 
were developed by the National Committee for Quality Assurance (NCQA).
VALUE SETS
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.196.12.1171
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.105.12.1004
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.114.12.1011
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113762.1.4.1
    VALUE SET VERSION DATE:   2012-10-25 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1001
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1008
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.114222.4.11.3591
    VALUE SET VERSION DATE:   2012-10-25 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1024
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1027
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1026
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1022
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.122.12.1003
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.526.3.1492
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.526.3.1496
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1055
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.114222.4.11.836
    VALUE SET VERSION DATE:   2012-10-25 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.106.12.1004
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1031
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1053
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.560.100.4
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.67.1.101.11.724
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1054
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1039
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.114222.4.11.837
    VALUE SET VERSION DATE:   2012-10-25 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1048
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1016
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1002
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1060
    VALUE SET VERSION DATE:   2013-06-14 00:00:00
GUID 703cc49b-b653-4885-80e8-245a057f5ae9
NQF NUMBER 0108
DESCRIPTION
Percentage of children 6-12 years of age and newly dispensed a medication 
for attention-deficit/hyperactivity disorder (ADHD) who had appropriate 
follow-up care.  Two rates are reported.  a. Percentage of children who 
had one follow-up visit with a practitioner with prescribing authority 
during the 30-Day Initiation Phase.b. Percentage of children who remained 
on ADHD medication for at least 210 days and who, in addition to the visit 
in the Initiation Phase, had at least two additional follow-up visits with 
a practitioner within 270 days (9 months) after the Initiation Phase ended.
CATEGORY Attribute
IDENTIFIER 136
STATUS Complete
TYPE PROCESS
MEASURE SET CY 2014 EP